Novel antihypertensive action of rutin is mediated via inhibition of angiotensin converting enzyme/mineralocorticoid receptor/angiotensin 2 type 1 receptor (ATR1) signaling pathways in uninephrectomized hypertensive rats

dc.contributor.authorOyagbemi, Ademola Adetokunbo
dc.contributor.authorBolaji-Alabi, Foluso Bolawaye
dc.contributor.authorAjibade, Temitayo Olabisi
dc.contributor.authorAdejumobi, Olumuyiwa Abiola
dc.contributor.authorAjani, Olumide Samuel
dc.contributor.authorJarikre, Theophilus Aghogho
dc.contributor.authorOmobowale, Temidayo Olutayo
dc.contributor.authorOla-Davies, Olufunke Eunice
dc.contributor.authorSoetan, Kehinde Olugboyega
dc.contributor.authorAro, Abimbola Obemisola
dc.contributor.authorEmikpe, Benjamin Obukowho
dc.contributor.authorSaba, Adebowale Benard
dc.contributor.authorAdedapo, Adeolu Alex
dc.contributor.authorOyeyemi, Matthew Olugbenga
dc.contributor.authorNkadimeng, Sanah Malomile
dc.contributor.authorKayoka-Kabongo, Prudence Ngalula
dc.contributor.authorMcGaw, Lyndy Joy
dc.contributor.authorOguntibeju, Oluwafemi Omoniyi
dc.contributor.authorYakubu, Momoh Audu
dc.date.accessioned2021-09-02T13:56:36Z
dc.date.issued2020-12
dc.description.abstractHypertension is the most common cardiovascular disease that affects approximately 26% of adult population, worldwide. Rutin is one of the important flavonoids that is consumed in the daily diet, and found in many food items, vegetables, and beverages. Uninephrectomy (UNX) of the left kidney was performed, followed by induction of hypertension. The rats were randomly divided into four groups of 10 rats: group 1—Sham-operated rats; group 2—UNX rats, group 3—UNX-L-NAME (40 mg/kg) plus rutin (100 mg/kg bwt), and groups 4—UNX-L-NAME plus lisinopril (10 mg/kg bwt), orally for 3 weeks. Results revealed significant heightening of arterial pressure and oxidative stress indices, while hypertensive rats treated with rutin had lower expressions of angiotensin converting enzyme (ACE) and mineralocorticoid receptor in uninephrectomized rats. Together, rutin as a novel antihypertensive flavonoid could provide an unimaginable benefits for the management of hypertension through inhibition of angiotensin converting enzyme and mineralocorticoid receptor. PRACTICAL APPLICATIONS : Hypertension has been reported to be the most common cardiovascular disease, affecting approximately 26% of the adult population worldwide with predicted prevalence to increase by 60% by 2025. Recent advances in phytomedicine have shown flavonoids to be very helpful in the treatment of many diseases. Flavonoids have been used in the treatment and management of cardiovascular diseases, obesity and hypertension. The study revealed that rutin, a known flavonoid inhibited angiotensin converting enzyme (ACE), angiotensin 2 type 1 receptor (ATR1), and mineralocorticoid receptor (MCR), comparable to the classic ACE inhibitor, Lisinopril, indicating the novel antihypertensive property of rutin. Therefore, flavonoids such as rutin found in fruits and vegetables could, therefore, serve as an antihypertensive drug regimen. Combining all, functional foods rich in flavonoids could be used as potential therapeutic candidates for managing uninephrectomized hypertensive patients.en_ZA
dc.description.departmentParaclinical Sciencesen_ZA
dc.description.embargo2021-10-21
dc.description.librarianhj2021en_ZA
dc.description.sponsorshipCape Peninsula University of Technology and National Research Foundation (South Africa)en_ZA
dc.description.urihttp://www.wileyonlinelibrary.com/journal/jfbcen_ZA
dc.identifier.citationOyagbemi AA, Bolaji-Alabi FB, Ajibade TO, et al. Novel antihypertensive action of rutin is mediated via inhibition of angiotensin converting enzyme/ mineralocorticoid receptor/angiotensin 2 type 1 receptor (ATR1) signaling pathways in uninephrectomized hypertensive rats. Journal of Food Biochemistry 2020;00:e13534. https://doi.org/10.1111/jfbc.13534.en_ZA
dc.identifier.issn0145-8884 (print)
dc.identifier.issn1745-4514 (online)
dc.identifier.other10.1111/jfbc.13534
dc.identifier.urihttp://hdl.handle.net/2263/81631
dc.language.isoenen_ZA
dc.publisherWileyen_ZA
dc.rights© 2020 Wiley Periodicals, Inc. This is the pre-peer reviewed version of the following article : Novel antihypertensive action of rutin is mediated via inhibition of angiotensin converting enzyme/ mineralocorticoid receptor/angiotensin 2 type 1 receptor (ATR1) signaling pathways in uninephrectomized hypertensive rats. Journal of Food Biochemistry 2020;00:e13534. https://doi.org/10.1111/jfbc.13534. The definite version is available at : http://www.wileyonlinelibrary.com/journal/jfbc.en_ZA
dc.subjectHypertensionen_ZA
dc.subjectMechanism of actionen_ZA
dc.subjectPhytochemicalen_ZA
dc.subjectRutinen_ZA
dc.subjectUninephrectomyen_ZA
dc.subjectAngiotensin converting enzyme (ACE)en_ZA
dc.subjectAngiotensin 2 type 1 receptor (ATR1)en_ZA
dc.subjectMineralocorticoid receptor (MCR)en_ZA
dc.subject.otherVeterinary science articles SDG-03en_ZA
dc.subject.otherSDG-03: Good health and well-being
dc.titleNovel antihypertensive action of rutin is mediated via inhibition of angiotensin converting enzyme/mineralocorticoid receptor/angiotensin 2 type 1 receptor (ATR1) signaling pathways in uninephrectomized hypertensive ratsen_ZA
dc.typePostprint Articleen_ZA

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
Oyagbemi_Novel_2020.pdf
Size:
679.94 KB
Format:
Adobe Portable Document Format
Description:
Postprint Article
Loading...
Thumbnail Image
Name:
Oyagbemi_NovelFigsS1-6_2020.ppt
Size:
1.24 MB
Format:
Microsoft Powerpoint
Description:
Figures S1-S6
Loading...
Thumbnail Image
Name:
Oyagbemi_NovelTabS1_2020.pdf
Size:
61.06 KB
Format:
Adobe Portable Document Format
Description:
Table S1

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: